PAR PHARM FDA Approval ANDA 090482

ANDA 090482

PAR PHARM

FDA Drug Application

Application #090482

Documents

Letter2017-06-21
Label2017-05-15

Application Sponsors

ANDA 090482PAR PHARM

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004
Prescription005

Application Products

001TABLET, EXTENDED RELEASE;ORALEQ 50MG BASE0QUETIAPINE FUMARATEQUETIAPINE FUMARATE
002TABLET, EXTENDED RELEASE;ORALEQ 150MG BASE0QUETIAPINE FUMARATEQUETIAPINE FUMARATE
003TABLET, EXTENDED RELEASE;ORALEQ 200MG BASE0QUETIAPINE FUMARATEQUETIAPINE FUMARATE
004TABLET, EXTENDED RELEASE;ORALEQ 300MG BASE0QUETIAPINE FUMARATEQUETIAPINE FUMARATE
005TABLET, EXTENDED RELEASE;ORALEQ 400MG BASE0QUETIAPINE FUMARATEQUETIAPINE FUMARATE

FDA Submissions

ORIG1AP2017-05-09

Submissions Property Types

ORIG1Null3

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB
005PrescriptionAB

CDER Filings

PAR PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90482
            [companyName] => PAR PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"QUETIAPINE FUMARATE","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 50MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"QUETIAPINE FUMARATE","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 150MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"QUETIAPINE FUMARATE","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 200MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"QUETIAPINE FUMARATE","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 300MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"QUETIAPINE FUMARATE","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 400MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"05\/09\/2017","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/090482Orig1s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"QUETIAPINE FUMARATE","submission":"QUETIAPINE FUMARATE","actionType":"EQ 50MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"QUETIAPINE FUMARATE","submission":"QUETIAPINE FUMARATE","actionType":"EQ 150MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"QUETIAPINE FUMARATE","submission":"QUETIAPINE FUMARATE","actionType":"EQ 200MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"QUETIAPINE FUMARATE","submission":"QUETIAPINE FUMARATE","actionType":"EQ 300MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"QUETIAPINE FUMARATE","submission":"QUETIAPINE FUMARATE","actionType":"EQ 400MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2017-05-09
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.